JIP
GSK icon

Jaffetilchin Investment Partners’s GSK GSK Stock Holding History

Jaffetilchin Investment Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-506
Closed -$20.7K – 746
2024
Q3 		$20.7K Buy
+506
New +$20.7K ﹤0.01% 756

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jaffetilchin Investment Partners's GSK Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of GSK (GSK) in Q4 2024, closing a stake of 506 shares — an estimated $20.7K sold.

Jaffetilchin Investment Partners first reported a position in GSK in Q3 2024 and held it in 1 quarter. The position peaked at $20.7K in Q3 2024. 849 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Jaffetilchin Investment Partners reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 506 GSK shares in Q4 2024, an estimated $20.7K.
  • Jaffetilchin Investment Partners first reported a position in GSK in Q3 2024 and held it in 1 quarter.
  • Jaffetilchin Investment Partners's GSK position peaked at $20.7K in Q3 2024.
  • 849 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.